In a rat model of type 2 diabetes, EPL reduced mitochondrial ROS production without changing mitochondrial transcription factor A or nuclear respiratory factor-1 expression, suggesting that EPL-mediated ROS reduction involves non-genomic mechanisms, including MAP kinases, protein kinase C, and phospholipase C [69]. The gene discussed is TFAM; the disease is type 2 diabetes mellitus.